Back to search

Article

Elevated Serum Growth Differentiation Factor 15 and Decorin Predict the Fibrotic Progression of Metabolic Dysfunction Associated Steatotic Liver Disease

2024-09-10

Abstract excerpt

<title>Abstract</title> <p>Background Mitochondrial dysfunction with oxidative stress contributes to metabolic dysfunction-associated steatotic liver disease (MASLD) progression. We aimed to evaluate the fibrosis predictive efficacy of a novel non-invasive diagnostic panel using metabolic stress biomarkers. Methods From a population-based general cohort, 343 volunteers were recruited in the development group an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
93515a31-6f1f-5d42-9566-826f87342a2b
DOI
10.21203/rs.3.rs-4854781/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Elevated Serum Growth Differentiation Factor 15 and Decorin Predict the Fibrotic Progression of Metabolic Dysfunction Associated Steatotic Liver DiseaseDOI 10.21203/rs.3.rs-4854781/v1
Metabolic Stress Index Including Mitochondrial Biomarker for Noninvasive Diagnosis of Hepatic SteatosisSemantic proximity
Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult PopulationSemantic proximity
Prevalence of Significant and Advanced Hepatic Fibrosis in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)Semantic proximity
High sensitivity C-reactive protein implicates heterogeneous metabolic phenotypes and severity in metabolic dysfunction associated-steatotic liver diseaseSemantic proximity
Unveiling the Burden of MASLD and Liver Fibrosis in India: Novel Insights from the Phenome India Study into fibrosis without MASLDSemantic proximity
Diagnostic performance of serum mac-2-binding protein glycosylation isomer as a fibrosis biomarker in non-obese and obese patients with MASLDSemantic proximity
Metabolic and Clinical Heterogeneity in MASLD Risk Stratification: Independent Effects of Body Mass Index and Fib-4 on Cirrhosis, and Clinical Implications of Noninvasive Score Discordance in a Veteran CohortSemantic proximity
Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessmentSemantic proximity
Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease.Semantic proximity
Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).Semantic proximity
High inherited risk predicts age-associated increases in fibrosis in patients with MASLD.Semantic proximity
Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with Metabolically Dysfunction Associated Steatotic Liver DiseaseSemantic proximity
Select a neighboring publication to make it the new centre.